Trial Profile
Effects of dapagliflozin on renal function in patients with type 2 diabetes [Diamond study-4]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jun 2019
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Diamond study-4
- 20 Jun 2019 Status changed from recruiting to completed.
- 20 May 2016 New trial record